Skip to main content
School of Medicine
Precision Health Initiative
Traumatic Brain Injury
Graduate Medical Education
Health Professions Programs
Continuing Medical Education
Mental Health Services
Centers and Institutes
Northwest - Gary
Anatomy, Cell Biology and Physiology
Biochemistry Molecular Biology
Biostatistics and Health Data Science
Microbiology and Immunology
Pharmacology and Toxicology
Medical and Molecular Genetics
Obstetrics and Gynecology
Physical Medicine and Rehabilitation
Radiology and Imaging Sciences
Toggle Search Box
Larry D. Cripe, MD
Larry D. Cripe, MD
Associate Professor of Medicine
Indiana Cancer Pavilion, Suite 473
535 Barnhill Dr
Indianapolis, IN 46202-5289
Titles & Appointments
Associate Professor of Medicine
Duke University Medical Center, Durham, NC
Rush Presbyterian St. Luke Medical Center, Chicago, IL
University of Chicago
Developmental therapeutics and supportive care measures
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study.
Ustun C; Le-Rademacher J; Wang HL; Othus M; Sun Z; Major B; Zhang MJ; Storrick E; Lafky JM; Chow S; Mrózek K; Attar EC; Nand S; Bloomfield CD; Cripe LD; Tallman MS; Appelbaum F; Larson RA; Marcucci G; Roboz GJ; Uy GL; Stone RM; Jatoi A; Shea TC; de Lima M; Foran JM; Sandmaier BM; Litzow MR; Erba HP; Hurria A; Weisdorf DJ; Artz AS; Leukemia 2019 May 9
Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P-glycoprotein modulation in acute myeloid leukemia.
Marcelletti JF; Sikic BI; Cripe LD; Paietta E; Cytometry. Part B, Clinical cytometry 2018 Oct 17
Ambulatory Advanced Cancer Patients' and Oncologists' Estimates of Life Expectancy Are Associated with Patient Psychological Characteristics But Not Chemotherapy Use.
Cripe LD; Rand KL; Perkins SM; Tong Y; Schmidt KK; Hedrick DG; Rawl SM; Journal of palliative medicine 2018 Jun 15
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience.
Ganzel C; Sun Z; Cripe LD; Fernandez HF; Douer D; Rowe JM; Paietta EM; Ketterling R; O'Connell MJ; Wiernik PH; Bennett JM; Litzow MR; Luger SM; Lazarus HM; Tallman MS; American journal of hematology 2018 Jun 15
Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials.
Sayar H; Cripe LD; Saliba AN; Abu Zaid M; Konig H; Boswell HS; Leukemia research 2018 Dec 24
Predicting symptoms of anxiety and depression in patients living with advanced cancer: the differential roles of hope and optimism.
Fischer IC; Cripe LD; Rand KL; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018 Apr 21
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.
Strickland SA; Sun Z; Ketterling RP; Cherry AM; Cripe LD; Dewald G; Fernandez HF; Hicks GA; Higgins RR; Lazarus HM; Litzow MR; Luger SM; Paietta EM; Rowe JM; Vance GH; Wiernik P; Wiktor AE; Zhang Y; Tallman MS; ECOG-ACRIN Cancer Research Group.; Leukemia research 2017 May 12
Dying From Cancer: Communication, Empathy, and the Clinical Imagination.
Cripe LD; Frankel RM; Journal of patient experience 2017 May 11
"My Future is Now": A Qualitative Study of Persons Living With Advanced Cancer.
Cottingham AH; Cripe LD; Rand KL; Frankel RM; The American journal of hospice & palliative care 2017 Jan 1
Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008.
Ganzel C; Manola J; Douer D; Rowe JM; Fernandez HF; Paietta EM; Litzow MR; Lee JW; Luger SM; Lazarus HM; Cripe LD; Wiernik PH; Tallman MS; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Oct 10
Physicians in Postgraduate Training Characteristics and Support of Palliative Sedation for Existential Distress.
Cripe LD; Perkins SM; Cottingham A; Tong Y; Kozak MA; Mehta R; The American journal of hospice & palliative care 2016 Jul 18
A PIECE OF MY MIND. Hope Is the Thing With Feathers.
Cripe LD; JAMA 2016 Jan 19
Life and treatment goals of patients with advanced, incurable cancer.
Rand KL; Banno DA; Shea AM; Cripe LD; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2016 Feb 11
Music Therapy Is Associated with Family Perception of More Spiritual Support and Decreased Breathing Problems in Cancer Patients Receiving Hospice Care.
Burns DS; Perkins SM; Tong Y; Hilliard RE; Cripe LD; Journal of pain and symptom management 2015 Mar 31
Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia.
Khawaja MR; Perkins SM; Schwartz JE; Robertson MJ; Kiel PJ; Sayar H; Cox EA; Vance GH; Farag SS; Cripe LD; Nelson RP Jr; American journal of hematology 2015 Feb
Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia.
Cesano A; Willman CL; Kopecky KJ; Gayko U; Putta S; Louie B; Westfall M; Purvis N; Spellmeyer DC; Marimpietri C; Cohen AC; Hackett J; Shi J; Walker MG; Sun Z; Paietta E; Tallman MS; Cripe LD; Atwater S; Appelbaum FR; Radich JP; PloS one 2015 Apr 17
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia.
Lancet JE; Roboz GJ; Cripe LD; Michelson GC; Fox JA; Leavitt RD; Chen T; Hawtin R; Craig AR; Ravandi F; Maris MB; Stuart RK; Karp JE; Haematologica 2014 Nov 7
Pilot study of erlotinib in patients with acute myeloid leukemia.
Sayar H; Czader M; Amin C; Cangany M; Konig H; Cripe LD; Leukemia research 2014 Dec 2
Discussions of life expectancy moderate relationships between prognosis and anxiety or depression in men with advanced cancer.
Cripe LD; Rawl SM; Schmidt KK; Tong Y; Monahan PO; Rand KL; Journal of palliative medicine 2012 Jan
Illness appraisal, religious coping, and psychological responses in men with advanced cancer.
Rand KL; Cripe LD; Monahan PO; Tong Y; Schmidt K; Rawl SM; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011 Sep 18
A noncanonical Flt3ITD/NF-?B signaling pathway represses DAPK1 in acute myeloid leukemia.
Shanmugam R; Gade P; Wilson-Weekes A; Sayar H; Suvannasankha A; Goswami C; Li L; Gupta S; Cardoso AA; Al Baghdadi T; Sargent KJ; Cripe LD; Kalvakolanu DV; Boswell HS; Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Nov 17
Thrice weekly azacitidine does not improve hematological responses in lower-risk myelodysplastic syndromes: a study of the Hoosier Oncology Group.
Sayar H; Chan RJ; Orschell CM; Chan EM; Yu Z; Hood D; Plett A; Yang Z; Hui CL; Nabinger SC; Kohlbacher KJ; West ES; Walter A; Sampson C; Wu J; Cripe LD; Leukemia research 2011 Mar 21
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.
Nelson RP Jr; Yu M; Schwartz JE; Robertson MJ; Hromas R; Fausel CA; Vance GH; Dlouhy SR; Baute JA; Cox EA; Wood LL; Srivastava S; Robertson KA; Haut PR; Farag SS; Abonour R; Cornetta K; Cripe LD; Bone marrow transplantation 2010 Jan 11
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.
Cripe LD; Uno H; Paietta EM; Litzow MR; Ketterling RP; Bennett JM; Rowe JM; Lazarus HM; Luger S; Tallman MS; Blood 2010 Aug 17
Cripe LD; Journal of palliative medicine 2009 Sep
Treating low-risk myelodysplastic syndromes in the community setting.
Cripe LD; Clinical advances in hematology & oncology : H&O 2008 Jun
Music imagery for adults with acute leukemia in protective environments: a feasibility study.
Burns DS; Azzouz F; Sledge R; Rutledge C; Hincher K; Monahan PO; Cripe LD; Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007 Sep 22
Final report of toxicity and efficacy of a phase II study of oral cyclophosphamide, thalidomide, and prednisone for patients with relapsed or refractory multiple myeloma: A Hoosier Oncology Group Trial, HEM01-21.
Suvannasankha A; Fausel C; Juliar BE; Yiannoutsos CT; Fisher WB; Ansari RH; Wood LL; Smith GG; Cripe LD; Abonour R; The oncologist 2007 Jan
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.
Cripe LD; Rader K; Tallman MS; Gordon MS; Paietta E; Bennett J; Neuberg D; Litzow MR; O'brien TE; Rowe JM; Leukemia research 2006 Jan 18
Desensitization to imatinib in patients with leukemia.
Nelson RP Jr; Cornetta K; Ward KE; Ramanuja S; Fausel C; Cripe LD; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006 Aug
A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group Study.
Ganjoo KN; Robertson MJ; Fisher W; Jung SH; McClean J; Huh SY; Bufill J; Williams S; Cripe LD; American journal of clinical oncology 2005 Apr
Oncologist Assisted Spiritual Intervention Study (OASIS): patient acceptability and initial evidence of effects.
Kristeller JL; Rhodes M; Cripe LD; Sheets V; International journal of psychiatry in medicine 2005
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Internal Medicine
Acute and chronic leukemia, myelodysplastic syndrome
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.
Find a doctor